Baxter, L. C., Caselli, R. J., Johnson, S. C., Reiman, E., Osborne, D. 2003. Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease. Neurobiology of Aging, 24, 947–952.
Blair, C. K. et al. 2005. APOE genotype and cognitive decline in a middle-aged cohort. Neurology, 64, 268–276.
Bretsky, P., Guralnik, J. M., Launer, L., Albert, M., Seeman, T. E. 2003. The role of APOE-ε4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology, 60, 1077–1081.
Brookmeyer, R., Gray, S. and Kawas, C. 1998. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. American Journal of Public Health, 88,1337–1342.
Caselli, R. J. et al. 1999. Preclinical memory decline in cognitively normal apolipoprotein E- ε4 homozygotes. Neurology, 53, 201–207.
Cohen, R. M., Small, C., Lalonde, F., Friz, J. and Sunderland, T. 2001. Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology, 57, 2223–2228.
Collie, A. et al. 2001. Memory decline in healthy older people: implications for identifying mild cognitive impairment. Neurology, 56, 1533–1538.
Corder, E. H. et al. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921–923.
Corder, E. H. et al. 1994 Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics, 7, 180–184.
Coroni-Huntley, J. et al. 1993. Established populations for epidemiologic studies of the elderly: study design and methodology. Aging (Milan), 5, 27–37.
Dik, M. G., Jonker, C., Bouter, L. M., Geerlings, M. I., van Kamp, G. J. and Deeg, D. J. 2000. APOE-ε4 is associated with memory decline in cognitively impaired elderly. Neurology, 54, 1492–1497.
Eaton, W. W. and Kessler, L. G. 1985. Epidemiologic Field Methods in Psychiatry: The NIMH Epidemiologic Catchment Area Program. Orlando, FL: Academic Press.
Eaton, W. W. et al. 1997. Natural history of Diagnostic Interview Schedule/DSM-IV major depression. The Baltimore Epidemiologic Catchment Area follow-up. Archives of General Psychiatry, 54, 993–999.
Fassbender, K., Masters, C. and Beyreuther, K. 2001. Alzheimer's disease: molecular concepts and therapeutic targets. Naturwissenschaften, 6, 261–267.
Feskens, E. J., Havekes, L. M., Kalmijn, S., de Knijff, P., Launer, L. J. and Kromhout, D. 1994. Apolipoprotein ε4 allele and cognitive decline in elderly men. BMJ, 309, 1202–1206.
Fillenbaum, G. G., Landerman, L. R., Blazer, D. G., Saunders, A. M., Harris, T. B. and Launer, L. J. 2001. The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents. Journal of the American Geriatrics Society, 49, 1148–1155.
Folstein, M. F., Folstein, S. E. and McHugh, P. R. 1975. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
Gomez-Isla, T. et al. 1996 Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease. Annals of Neurology, 39, 62–70.
Helkala, E. L. et al. 1996 Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study. Neuroscience Letters, 204, 177–180.
Hyman, B. T. 1996. Apolipoprotein E genotype: utility in clinical practice in Alzheimer's disease. Journal of the American Geriatrics Society, 44, 1469–1471.
Hyman, B. T. et al. 1995 Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proceedings of the National Academy of Science, U.S.A., 92, 3586–3590.
Jonker, C., Schmand, B., Lindeboom, J., Havekes, L. M. and Launer, L. J. 1998. Association between apolipoprotein E ε4 and the rate of cognitive decline in community dwelling elderly individuals with and without dementia. Archives of Neurology, 55, 1065–1069.
Kang, J. H., Logroscino, G., De Vivo, I., Hunter, D. and Grodstein, F. 2005. Apolipoprotein E, cardiovascular disease and cognitive function in aging women. Neurobiology of Aging, 26, 475–484.
Khachaturian, A. S., Corcoran, C. D., Mayer, L. S., Zandi, P. P. and Breitner, J. C. 2004. Cache County Study Investigators. Apolipoprotein E ε4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study. Archives of General Psychiatry, 61, 518–524.
Kuller, L. et al. 1998. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke, 29, 388–398.
Lahoz, C. et al. 2001. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis, 154, 529–537.
Laird, N. M. and Ware, J. H. 1982. Random-effects models for longitudinal data. Biometrics, 38, 963–974.
Mayeux, R., Small, S. A., Tang, M., Tycko, B. and Stern, Y. 2001. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E. Neurobiology of Aging, 22, 683–689.
McCarron, M. O., Delong, D. and Alberts, M. J. 1999. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology, 53, 1308–1311.
Mortensen, E. L. and Hogh, P. 2001. A gender difference in the association between APOE genotype and age-related cognitive decline, Neurology, 57, 89–95.
O'Hara, R., Yesavage, J. A., Kraemer, H. C., Mauricio, M., Friedman, L. F. and Murphy, G. M. Jr. 1998 The APOE ε4 allele is associated with decline on delayed recall performance in community-dwelling older adults. Journal of the American Geriatrics Society, 46, 1493–1498.
Ohm, T. G., Kirca, M., Bohl, J., Scharnagl, H., Gross, W. and Marz, W. 1995. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience, 66, 583–587.
Pirttila, T. et al. 1997. Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains. Neurobiology of Aging, 18, 121–127.
Polvikoski, T. et al. 1995. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. The New England Journal of Medicine, 333, 1242–1247.
Riley, K. P., Snowdon, D. A., Saunders, A. M., Roses, A. D., Mortimer, J. A. and Nanayakkara, N. 2000 Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study. Journals of Gerontology Series B: Biological Sciences and Medical Sciences, 55, S69–S75.
Robins, L. N., Helzer, J. E., Croughan, J. and Ratcliff, K. 1981 National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Archives of General Psychiatry, 38, 381–389.
Saunders, A. M. et al. 1993. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43, 1467–1472.
Schmechel, D. E. et al. 1993. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proceedings of the National Academy of Science, U.S.A., 90, 9649–9653.
Sparks, D. L. 1997. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Annals of the New York Academy of Science, 826, 128–146.
Stengard, J. H., Weiss, K. M. and Sing, C. F. 1998. An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E. Human Genetics, 103, 234–241.
St.George-Hyslop, P. H. 2000. Genetic factors in the genesis of Alzheimer's disease. Annals of the New York Academy of Science, 924, 1–7.
Talbot, C., Lendon, C., Craddock, N., Shears, S., Morris, J.C. and Goate, A. 1994. Protection against Alzheimer's disease with apoE ε2. Lancet, 343, 1432–1433.
Tombaugh, T. N. and McIntyre, N. J. 1992. The mini-mental state examination: a comprehensive review. Journal of the American Geriatrics Society, 40, 922–935.
Wilson, P. W., Schaefer, E. J., Larson, M. G. and Ordovas, J. M. 1996. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arteriosclerosis, Thrombosis, and Vascular Biology, 16, 1250–1255.
Wilson, R. S. et al. 2002. The apolipoprotein ε 4 allele and decline in different cognitive systems during a 6-year period. Archives of Neurology, 59, 1154–1160.
Winnock, M., Letenneur, L., Jacqmin-Gadda, H., Dallongeville, J., Amouyel, P. and Dartigues, J. F. 2002. Longitudinal analysis of the effect of apolipoprotein E epsilon4 and education on cognitive performance in elderly subjects: the PAQUID study. Journal of Neurology, Neurosurgery, and Psychiatry, 72, 794–797.
Yaffe, K., Cauley, J., Sands, L. and Browner, W. 1997. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Archives of Neurology, 54, 1110–1114.